Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Cash & Current Investments (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Cash & Current Investments for 17 consecutive years, with $158.4 million as the latest value for Q1 2026.

  • Quarterly Cash & Current Investments fell 12.87% to $158.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $158.4 million through Jan 2026, down 12.87% year-over-year, with the annual reading at $158.4 million for FY2026, 12.87% down from the prior year.
  • Cash & Current Investments for Q1 2026 was $158.4 million at Usana Health Sciences, up from $145.3 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $364.9 million in Q3 2024, with the low at $145.3 million in Q3 2025.
  • Average Cash & Current Investments over 5 years is $254.0 million, with a median of $246.9 million recorded in 2022.
  • The sharpest move saw Cash & Current Investments skyrocketed 30.3% in 2023, then plummeted 60.17% in 2025.
  • Over 5 years, Cash & Current Investments stood at $288.4 million in 2022, then rose by 14.56% to $330.4 million in 2023, then plummeted by 44.99% to $181.8 million in 2024, then fell by 20.04% to $145.3 million in 2025, then rose by 8.97% to $158.4 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $158.4 million, $145.3 million, and $151.3 million for Q1 2026, Q3 2025, and Q2 2025 respectively.